Ro vs Henry Meds comes down to a tradeoff between vertically integrated pharmacy infrastructure and a more bundled, no-separate-fee pricing model. Ro owns its own pharmacy and bills tirzepatide around $244–$264/month all-in (medication plus a $99/month Body membership). Henry Meds bundles everything into roughly $199/month for tirzepatide with no separate membership fee. Luma Health undercuts both at $165/month flat, with a clinical team focused specifically on metabolic health.
Ro vs Henry Meds: What You Need to Know
Choosing between Ro and Henry Meds for GLP-1 weight loss is one of the most common comparisons patients face in the telehealth market today. Ro is a well-funded telehealth platform that owns its own pharmacy infrastructure and offers optional video consultations. Henry Meds is a more narrowly focused entrant that has built its reputation around bundled, relatively transparent pricing for compounded GLP-1 medications. Both prescribe compounded semaglutide and compounded tirzepatide for weight loss through online consultations.
Neither Ro nor Henry Meds is a dedicated weight management clinic. Ro covers dozens of health categories including hair loss, sexual health, dermatology, and mental health. Henry Meds spans several telehealth niches beyond weight loss as well. This distinction matters because specialized providers who focus exclusively on metabolic health and GLP-1 therapy can offer deeper clinical specialization and more individualized dose titration than a generalist platform handling unrelated conditions in parallel.
Ro vs Henry Meds vs Luma Health: Full Comparison Table
| Feature | Ro | Henry Meds | Luma Health |
|---|---|---|---|
| Semaglutide Price | $145/mo + $99 membership = $244/mo | $145/mo all-in | $90/mo flat |
| Tirzepatide Price | $145–$165/mo + $99 membership = $244–$264/mo | $199/mo all-in | $165/mo flat |
| Consultation Fee | Included in membership | None (bundled) | Included |
| Own Pharmacy | Yes (Ro Pharmacy) | No, third-party | Partner pharmacy (VialsRX, licensed 503A) |
| Consultation Model | Async + optional video | Async only | Async, same-day to 24–48hr review |
| Contract Required | Some plans: 3 months | Monthly | No — month-to-month |
| Provider Focus | Multi-category generalist | Multi-category telehealth | Weight management specialist |
| Avg. Delivery Time | 7–14 days | 7–14 days | 5–10 days |
⚠ Pricing Note
Telehealth pricing changes frequently and varies by plan tier, promotion, and dose level. Always verify current pricing directly with each provider before enrolling — the figures above reflect publicly reported rates as of June 2026.
Pricing Deep Dive: Total Cost of Treatment
Price is the most searched factor in any Ro-versus-competitor comparison, and the differences are more significant than headline numbers suggest. The total cost of GLP-1 treatment extends beyond the advertised monthly medication price to include membership fees, dose-tier escalation, and any contractual commitments that lock in multi-month spending.
Ro Pricing Breakdown
Ro Body Program requires a separate $99/month membership (discounted to $45 for the first month) layered on top of $145–$165/month for medication, bringing the true all-in cost to $244–$264/month for tirzepatide. Most Ro plans bundle clinical support, optional insurance navigation, and a tracking dashboard into that membership fee. Some plans require a 3-month minimum commitment.
Henry Meds Pricing Breakdown
Henry Meds charges approximately $145/month for compounded semaglutide and $199/month for compounded tirzepatide, generally bundled with no separate membership or consultation fee layered on top — a genuine structural advantage over Ro's two-charge model, even though the headline tirzepatide rate is still $34/month above Luma Health's flat $165/month.
Luma Health Pricing Comparison
Luma Health offers compounded semaglutide at $90/month and compounded tirzepatide at $165/month flat, with all consultations, dose adjustments, and ongoing clinical support included and no separate fees of any kind. No contracts are required. Over a 6-month tirzepatide course, total Luma Health cost is $990, compared to $1,464–$1,584 at Ro and $1,194 at Henry Meds for the same general category of compounded medication.
Medications: Semaglutide and Tirzepatide Access
Both Ro and Henry Meds offer compounded versions of the two most clinically validated GLP-1 medications for weight loss: semaglutide and tirzepatide. These are not the brand-name formulations (Wegovy and Zepbound) but compounded equivalents produced by 503A sterile compounding pharmacies under state board of pharmacy oversight and USP <797> sterile-compounding standards. The active pharmaceutical ingredient is the same, though compounded formulations may differ in concentration, excipients, and delivery device across providers.
Semaglutide is a GLP-1 receptor agonist that demonstrated approximately 14.9% mean body weight loss in the STEP 1 trial involving 1,961 participants over 68 weeks. Tirzepatide is a dual GIP/GLP-1 receptor agonist that demonstrated even greater efficacy, with participants losing up to approximately 22.5% of body weight at the highest dose in the SURMOUNT-1 trial involving 2,539 participants. Both medications work by reducing appetite, slowing gastric emptying, and improving metabolic signaling.
Ro's access to tirzepatide has historically been relatively consistent, likely because Ro Pharmacy's vertical integration provides direct supply chain control. Henry Meds relies on third-party pharmacy partners, which can introduce more variability in tirzepatide availability depending on raw material supply and compounding capacity at any given time. For patients who specifically want tirzepatide, confirming current availability before enrolling with any provider — Ro, Henry Meds, or otherwise — is worth doing directly.
Luma Health offers both compounded semaglutide and compounded tirzepatide with consistent availability through VialsRX, a licensed 503A sterile compounding pharmacy. Patients switching from either Ro or Henry Meds can typically transfer their current dose without restarting the titration process, provided they share accurate dosing history during intake.
Provider Model: How Clinical Care Differs
The provider model is where the difference between a generalist telehealth platform and a specialized weight management clinic becomes most apparent. Both Ro and Henry Meds use telehealth consultations to evaluate patients and prescribe GLP-1 medications, but the depth and focus of that clinical interaction varies.
Ro uses a network of licensed providers and nurse practitioners who handle consultations across multiple health categories. The initial evaluation is typically asynchronous — patients complete a medical questionnaire and a provider reviews it and makes a prescribing decision — though Ro also offers optional video consultations for patients who want face-to-face interaction. The strength of this model is accessibility and the option for live conversation. The limitation is that your provider may also be handling hair loss, sexual health, and dermatology cases alongside your weight management, which can dilute specialization.
Henry Meds uses asynchronous telehealth consultations as its primary model, with video consultations more limited compared to Ro. Follow-up support is messaging-based. The bundled, no-separate-fee pricing structure means patients aren't paying extra for consultation access, but the depth of provider engagement is comparable to or somewhat lighter than Ro's optional video model.
Why Specialization Matters for GLP-1 Treatment
GLP-1 dose titration is not a one-size-fits-all process. Optimal results require individualized adjustments based on tolerance, side effect profile, metabolic response, and patient goals. Cardiovascular outcomes research has further underscored the importance of sustained, well-managed GLP-1 treatment specifically — benefits that depend on consistent dosing and proper clinical follow-through, not just initial prescription approval. Generalist providers who handle dozens of unrelated health categories may default to standard protocols without the nuanced, ongoing adjustments that a dedicated metabolic health specialist would make. Luma Health's clinical team through Wasef Health, PC handles GLP-1 therapy as its primary clinical focus, which supports more individualized titration and follow-up.
Where Each Provider Has the Advantage
Ro's Advantages
- Vertically integrated pharmacy (Ro Pharmacy) gives direct control over compounding quality and fulfillment consistency
- Optional video consultations for patients who want live provider interaction
- More established brand and operational track record
- Insurance navigation assistance available for brand-name medication pathways
Henry Meds's Advantages
- Simpler bundled pricing — no separate membership fee layered on top of medication
- Lower headline tirzepatide cost than Ro's all-in total
- Pricing presentation tends to be more transparent at a glance
Who Should Choose Which
Choose Ro if vertically integrated pharmacy control and the option for live video consultations matter more to you than minimizing monthly cost, or if you specifically want insurance navigation assistance for brand-name medication.
Choose Henry Meds if you want simpler, bundled pricing without a separate membership fee and are comfortable with an async-only consultation model.
Choose Luma Health if you want the lowest all-in monthly cost among the three ($165/month flat for tirzepatide, no membership, no consultation fee), plus a clinical team whose primary focus is metabolic health rather than one category among dozens.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1). NEJM. 2021;384:989–1002. n=1,961 participants; 14.9% mean body weight reduction at 68 weeks.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity" (SURMOUNT-1). NEJM. 2022;387:205–216. n=2,539 participants; up to 22.5% mean body weight reduction at the highest dose.
- Lincoff AM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes" (SELECT). NEJM. 2023;389:2221–2232.
Frequently Asked Questions
Henry Meds is generally cheaper for tirzepatide on a true all-in basis (approximately $199/month vs. Ro's $244–$264/month including the Body membership). Both are more expensive than specialist flat-fee providers like Luma Health, which charges $165/month for tirzepatide with no membership fee.
Ro has built vertically integrated pharmacy infrastructure (often referred to as Ro Pharmacy) that gives the company more direct control over compounding and fulfillment than platforms relying entirely on third-party pharmacy partners. This is a genuine structural advantage for supply consistency, though it doesn't change the underlying active ingredient in the medication itself.
Ro's vertically integrated pharmacy has historically provided more consistent tirzepatide availability than Henry Meds, which relies on third-party pharmacy partners more susceptible to supply variability. Always confirm current availability directly with either provider before enrolling specifically for tirzepatide.
Yes. Start Luma Health's intake first and confirm your prescription is approved and shipping before canceling your current provider. If switching from Ro, remember to cancel both the Body membership and the medication subscription separately. Share your current dose and titration history so Luma Health's clinical team can continue treatment without restarting.
Yes. Both are legitimate telehealth platforms using licensed providers and compounding pharmacies meeting state and federal regulatory standards. This comparison is about cost, pharmacy model, and clinical specialization — not legitimacy.